API Product   :    Atropine Sulfate
CEP   :    ¤
WCC   :    ?
Therapeutic Use    :    All Other Therapeutic Products; Ophthalmologicals; Antacids, antiflatulents and anti-ulcerants; Functional gastro-intestinal disorder drugs; Cardiac therapy; Cough And Cold Preparations
All Other Therapeutic Products; Ophthalmologicals; Antacids, antiflatulents and anti-ulcerants; Functional gastro-intestinal disorder drugs; Cardiac therapy; Cough And Cold Preparations
Originator   :    Fresenius Kabi
CAS No.    :    51-55-8
Trade Name.   :    ATROPINE SULF
Molecular Weight   :    289.369 g/mol
Molecular Formula   :    C17H23NO3
Atropine Injection is given before anaesthesia to decrease mucus secretions, such as saliva. During anaesthesia and surgery, atropine is used to help keep the heart beat normal. Atropine sulfate is also used to block or reverse the adverse effects caused by some medicines and certain type of pesticides.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system.